Multisystem involvement may be a sign of ATTR

ATTR develops due to the accumulation of amyloid deposits in the heart and other tissues of the body.1-4
Select the tabs below to explore red-flag signs and symptoms.
A diagram showing symptom areas of ATTR amyloidosis A diagram showing symptom areas of ATTR amyloidosis
Tap the hot spots to explore the cardiac red-flag symptoms
*Including ARNi, ACEi, ARB, or beta blockers.
  • LV wall thickening in the absence of hypertension
  • Conduction system disease, atrial fibrillation
  • Aortic stenosis (particularly low-flow/low grade)
  • HFpEF alone or in combination with other noncardiac red-flag symptoms
  • Intolerance to common HF medications*
  • Elevated NT-proBNP and troponin I
  • Shortness of breath
  • Edema
A diagram showing symptom areas of ATTR amyloidosis A diagram showing symptom areas of ATTR amyloidosis
Tap the hot spots to explore the neurologic red-flag symptoms
  • Orthostatic hypotension
  • Recurrent urinary tract infections
  • Sexual dysfunction
  • Altered sensation
  • Length-dependent neuropathic pain and weakness
  • Difficulty walking
A diagram showing symptom areas of ATTR amyloidosis A diagram showing symptom areas of ATTR amyloidosis
Tap the hot spots to explore the musculoskeletal red-flag symptoms
  • Rotator cuff injury
  • Biceps tendon rupture
  • Lumbar spinal stenosis
  • Bilateral CTS
  • Trigger finger
A diagram showing symptom areas of ATTR amyloidosis A diagram showing symptom areas of ATTR amyloidosis
Tap the hot spot to explore the gastrointestinal red-flag symptoms
  • Diarrhea
  • Constipation
  • Nausea
  • Vomiting
  • Unintentional weight loss
A diagram showing symptom areas of ATTR amyloidosis A diagram showing symptom areas of ATTR amyloidosis
Tap the hot spot to explore the ocular red-flag symptoms
  • Vitreous opacification
  • Glaucoma
  • Abnormal conjunctival vessels
  • Pupillary abnormalities 
A diagram showing symptom areas of ATTR amyloidosis A diagram showing symptom areas of ATTR amyloidosis
Tap the hot spot to explore the renal red-flag symptoms
  • Proteinuria
  • Renal failure

  • LV wall thickening in the absence of hypertension
  • Conduction system disease, atrial fibrillation
  • Aortic stenosis (particularly low-flow/low grade)
  • HFpEF alone or in combination with other noncardiac red-flag symptoms
  • Intolerance to common HF medications*
  • Elevated NT-proBNP and troponin I
  • Shortness of breath
  • Edema
*Including ARNi, ACEi, ARB, or beta blockers.

  • Orthostatic hypotension
  • Recurrent urinary tract infections
  • Sexual dysfunction
  • Altered sensation
  • Length-dependent neuropathic pain and weakness
  • Difficulty walking

  • Rotator cuff injury
  • Biceps tendon rupture
  • Lumbar spinal stenosis
  • Bilateral CTS
  • Trigger finger

  • Diarrhea
  • Constipation
  • Nausea
  • Vomiting
  • Unintentional weight loss

  • Vitreous opacification
  • Glaucoma
  • Abnormal conjunctival vessels
  • Pupillary abnormalities 

  • Proteinuria
  • Renal failure

Not a comprehensive list of all the symptoms associated with ATTR amyloidosis. Each patient may not experience all of these symptoms or may not experience them at the same time.

Download the Red-flag Symptoms Flashcard Arrow right Arrow right
ACEi=angiotensin-converting enzyme inhibitor; ARB=angiotensin receptor blocker; ARNi=angiotensin receptor-neprilysin inhibitor; ATTR=transthyretin-mediated amyloidosis; CTS=carpal tunnel syndrome; HF=heart failure; HFpEF=heart failure with preserved ejection fraction; LV=left ventricular; NT-proBNP=N-terminal prohormone of brain-type natriuretic peptide.
NEXT

Suspecting ATTR Arrow right Arrow right

Arrow right

References:

  1. Koike H et al. Biomedicines. 2019;7(1):11.
  2. Adams D et al. Neurology. 2015;85(8):675-682.
  3. Adams D et al. Curr Opin Neurol. 2016;29(suppl 1):S14-S26.
  4. Mohty D et al. Arch Cardiovasc Dis. 2013;106(10):528-540.
  5. Kittleson MM et al. Circulation. 2020;142(1):e7-e22.
  6. Kittleson MM et al. J Am Coll Cardiol. 2023;81(11):1076-1126.
  7. Maurer MS et al. Circ Heart Fail. 2019;12(9):e006075.
  8. González-López E et al. Eur Heart J. 2015;36(38):2585-2594.
  9. Maloberti A et al. Int J Cardiol Cardiovasc Risk Prev. 2024;21:200271.
  10. Dharmarajan K et al. J Am Geriatr Soc. 2012;60(4):765-774.
  11. Castaño A et al. Eur Heart J. 2017;38(38):2879-2887.
  12. Conceição I et al. J Peripher Nerv Syst. 2016;21(1):5-9.
  13. Witteles RM et al. JACC Heart Fail. 2019 Aug;7(8):709-716.
  14. Nativi-Nicolau JN et al. Heart Fail Rev. 2022;27(3):785-793.
  15. Brito D et al. Glob Heart. 2023;18(1):1-47.
  16. Mitter SS et al. ISA Congress 2020. Poster PT135.
  17. Rintell et al. Orphanet J Rare Dis. 2021;16(1):70.
  18. Maurer MS et al. J Am Coll Cardiol. 2016;68(2):161-172.
  19. Rozenbaum MH et al. Cardiol Ther. 2021;10(1):141-159.